CIK 0001355790
- Non-accelerated filer
- Smaller reporting company
International Stem Cell CORP
Sign in to watch- Ticker
- ISCO
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 204494098
- Phone
- +1 760-940-6383
- Business address
- 9745 BUSINESSPARK AVENUE, SAN DIEGO, CA, 92131
- Former names
- BTHC III INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,497
- in 1 filing
Net −$10,497. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-03-12 | Bakalova Sofya Vice President | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2015-03-06 | CASAMENTO CHARLES J Director | Grant or award | +76,958 | 571,611 | ||
| 2015-02-23 | Semechkin Ruslan Chief Scientific Officer | Purchase | +1,861,331 | $0.04 | $83K | 7,541,384 |
| 2015-02-23 | Semechkin Ruslan Chief Scientific Officer | Option exercise · Series B Warrant (Right to Buy) | −1,861,331 | 0 | ||
| 2014-12-22 | Semechkin Andrey Chief Executive Officer | Purchase | +5,894,214 | $0.06 | $340K | 54,249,307 |
| 2014-12-22 | Semechkin Andrey Chief Executive Officer | Option exercise · Series B Warrant (Right to Buy) | −5,894,214 | 0 | ||
| 2014-11-10 | Semechkin Ruslan Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2014-11-10 | Semechkin Andrey Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2014-11-10 | Novak Tibor Jay Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2014-11-10 | Craw John Simon Executive Vice President | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2014-11-10 | Bakalova Sofya Vice President | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2014-10-14 | Semechkin Andrey Chief Executive Officer | Purchase · Series H-2 Preferred Stock | +380 | $1,000.00 | $380K | 380 |
| 2014-10-14 | Semechkin Andrey Chief Executive Officer | Purchase · Series A Warrant (Right to Buy) | +5,894,214 | 5,894,214 | ||
| 2014-10-14 | Semechkin Andrey Chief Executive Officer | Purchase · Series B Warrant (Right to Buy) | +5,894,214 | 5,894,214 | ||
| 2014-10-14 | Semechkin Andrey Chief Executive Officer | Purchase · Series C Warrant (Right to Buy) | +5,894,214 | 5,894,214 | ||
| 2014-10-14 | Semechkin Ruslan Chief Scientific Officer | Purchase · Series H-2 Preferred Stock | +120 | $1,000.00 | $120K | 120 |
| 2014-10-14 | Semechkin Ruslan Chief Scientific Officer | Purchase · Series A Warrant (Right to Buy) | +1,861,331 | 1,861,331 | ||
| 2014-10-14 | Semechkin Ruslan Chief Scientific Officer | Purchase · Series B Warrant (Right to Buy) | +1,861,331 | 1,861,331 | ||
| 2014-10-14 | Semechkin Ruslan Chief Scientific Officer | Purchase · Series C Warrant (Right to Buy) | +1,861,331 | 1,861,331 | ||
| 2014-10-10 | Novak Tibor Jay Chief Financial Officer | Purchase | +10,000 | $0.10 | $1K | 40,000 |
Page 12 of 15 · 298 trades